<NOTICE>
DEPARTMENT OF HEALTH AND HUMAN SERVICES
<SUBAGY>National Institutes of Health</SUBAGY>
<SUBJECT>Center for Scientific Review; Notice of Closed Meetings</SUBJECT>
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
<EXTRACT>
<E T="03">Name of Committee:</E>
Center for Scientific Review Special Emphasis Panel; Program Project: Cancer Research.
<E T="03">Date:</E>
June 25-26, 2025.
<E T="03">Time:</E>
9:00 a.m. to 6:00 p.m.
<E T="03">Agenda:</E>
To review and evaluate grant applications.
<E T="03">Address:</E>
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
<E T="03">Meeting Format:</E>
Virtual Meeting.
<E T="03">Contact Person:</E>
Michael Edward Lindquist, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, 9609 Medical Center Drive, 7W634, National Cancer Institute, NIH, Rockville, MD 20850, (240) 276-5735,
<E T="03">mike.lindquist@nih.gov.</E>
<E T="03">Name of Committee:</E>
Oncology 2—Translational Clinical Integrated Review Group; Cellular Immunotherapy of Cancer Study Section.
<E T="03">Date:</E>
June 26-27, 2025.
<E T="03">Time:</E>
8:30 a.m. to 6:30 p.m.
<E T="03">Agenda:</E>
To review and evaluate grant applications.
<E T="03">Address:</E>
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
<E T="03">Meeting Format:</E>
Virtual Meeting.
<E T="03">Contact Person:</E>
Shahana Majid, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,
<E T="03">shahana.majid@nih.gov.</E>
<E T="03">Name of Committee:</E>
Center for Scientific Review Special Emphasis Panel; Program Project: Cancer Research.
<E T="03">Date:</E>
June 26-27, 2025.
<E T="03">Time:</E>
9:00 a.m. to 6:00 p.m.
<E T="03">Agenda:</E>
To review and evaluate grant applications.
<E T="03">Address:</E>
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
<E T="03">Meeting Format:</E>
Virtual Meeting.
<E T="03">Contact Person:</E>
Majed M. Hamawy, Ph.D., MBA Scientific Review Officer, Research
Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Dr., Rm. 7w120, Bethesda, MD 20892, 240-276-6457,
<E T="03">mh101v@nih.gov.</E>
<E T="03">Name of Committee:</E>
Healthcare Delivery and Methodologies Integrated Review Group; Healthcare and Health Disparities Study Section.
<E T="03">Date:</E>
June 26-27, 2025.
<E T="03">Time:</E>
9:00 a.m. to 6:00 p.m.
<E T="03">Agenda:</E>
To review and evaluate grant applications.
<E T="03">Address:</E>
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
<E T="03">Meeting Format:</E>
Virtual Meeting.
<E T="03">Contact Person:</E>
Tara Roshell Earl, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1007C, Bethesda, MD 20892, (301) 402-6857,
<E T="03">earltr@mail.nih.gov.</E>
<E T="03">Name of Committee:</E>
Infectious Diseases and Immunology A Integrated Review Group; Innate Immunity B Study Section.
<E T="03">Date:</E>
June 26-27, 2025.
<E T="03">Time:</E>
9:30 a.m. to 7:00 p.m.
<E T="03">Agenda:</E>
To review and evaluate grant applications.
<E T="03">Address:</E>
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
<E T="03">Meeting Format:</E>
Virtual Meeting.
<E T="03">Contact Person:</E>
Bakary Drammeh, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 805-P, Bethesda, MD 20892, (301) 435-0000,
<E T="03">drammehbs@csr.nih.gov.</E>
<E T="03">Name of Committee:</E>
Infectious Diseases and Immunology B Integrated Review Group; Etiology, Diagnostic, Intervention and Treatment of Infectious Diseases Study Section.
<E T="03">Date:</E>
June 26-27, 2025.
<E T="03">Time:</E>
9:30 a.m. to 6:30 p.m.
<E T="03">Agenda:</E>
To review and evaluate grant applications.
<E T="03">Address:</E>
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
<E T="03">Meeting Format:</E>
Virtual Meeting.
<E T="03">Contact Person:</E>
Lisa Ann Lewis, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-2582,
<E T="03">lisa.lewis3@nih.gov.</E>
<E T="03">Name of Committee:</E>
Oncology 1—Basic Translational Integrated Review Group; Tumor Host Interactions Study Section.
<E T="03">Date:</E>
June 26-27, 2025.
<E T="03">Time:</E>
9:30 a.m. to 6:00 p.m.
<E T="03">Agenda:</E>
To review and evaluate grant applications.
<E T="03">Address:</E>
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
<E T="03">Meeting Format:</E>
Virtual Meeting.
<E T="03">Contact Person:</E>
Angela Y. Ng, Ph.D., MBA Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 710-C, MSC 7806, Bethesda, MD 20892, (301) 435-1715,
<E T="03">nga@csr.nih.gov.</E>
<E T="03">Name of Committee:</E>
Cardiovascular and Respiratory Sciences Integrated Review Group; Clinical Integrative Cardiovascular and Hematological Sciences Study Section.
<E T="03">Date:</E>
June 26-27, 2025.
<E T="03">Time:</E>
9:30 a.m. to 7:00 p.m.
<E T="03">Agenda:</E>
To review and evaluate grant applications.
<E T="03">Address:</E>
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
<E T="03">Meeting Format:</E>
Virtual Meeting.
<E T="03">Contact Person:</E>
Marie-Luise Brennan, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-0732,
<E T="03">marie-luise.brennan@nih.gov.</E>
<E T="03">Name of Committee:</E>
Infectious Diseases and Immunology B Integrated Review Group; Immunity and Host Defense Study Section.
<E T="03">Date:</E>
June 26-27, 2025.
<E T="03">Time:</E>
9:30 a.m. to 6:30 p.m.
<E T="03">Agenda:</E>
To review and evaluate grant applications.
<E T="03">Address:</E>
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
<E T="03">Meeting Format:</E>
Virtual Meeting.
<E T="03">Contact Person:</E>
Alok Mulky, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4203, Bethesda, MD 20892, (301) 435-3566,
<E T="03">mulkya@mail.nih.gov.</E>
<E T="03">Name of Committee:</E>
Center for Scientific Review Special Emphasis Panel; Cardiovascular Differentiation and Development.
<E T="03">Date:</E>
June 26, 2025.
<E T="03">Time:</E>
9:30 a.m. to 7:00 p.m.
<E T="03">Agenda:</E>
To review and evaluate grant applications.
<E T="03">Address:</E>
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
<E T="03">Meeting Format:</E>
Virtual Meeting.
<E T="03">Contact Person:</E>
Sara Ahlgren, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Rm. 4136, Bethesda, MD 20892, 301-435-0904,
<E T="03">sara.ahlgren@nih.gov.</E>
<FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)</FP>
</EXTRACT>
<SIG>
<DATED>Dated: May 22, 2025.</DATED>
<NAME>Lauren B. Gibson,</NAME>
Program Analyst, Office of Federal Advisory Committee Policy.
</SIG>
<FRDOC>[FR Doc. 2025-09613 Filed 5-28-25; 8:45 am]</FRDOC>
</NOTICE>
This text is preserved for citation and comparison. View the official version for the authoritative text.